ArticleAMB Express2025
Inflammation biomarkers mediate causal inference of the effect of skin microbiota on the risk of allergic diseases.
Article in AMB Express, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Host mScientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Alterations in skin microbiota composition have been linked to allergic diseases, but the causal relationship remains unclear. To investigate the causal relationship between skin microbiota, allergic diseases, and inflammation biomarkers using Mendelian randomization (MR). We integrated summary statistics from genome-wide association studies (GWAS) of skin microbiota inflammation biomarkers, and seven allergic diseases. Inverse variance weighting (IVW) served as the primary statistical method, with supplementary analyses using MR-Egger regression, weighted median, and Weighted mode. Sensitivity analyses, including Cochran's Q test, MR-Egger intercept test and MR-PRESSO outlier detection, were conducted to validate and stabilize our findings. Two-step MR analyses were performed to identify potential mediating inflammation biomarkers between skin microbiota and allergic diseases.We identified 43 significant causal relationships between the skin microbiota and seven allergic diseases: allergic disease as a whole, asthma (adult, pediatric, allergic), allergic conjunctivitis, allergic rhinitis, atopic dermatitis, allergic urticaria and eczema, which included 20 protective and 23 risk causal relationships, respectively. Mediation analysis showed that specific biomarkers, such as C-C motif chemokine 19 and CD40L receptor levels, Interleukin-18 and TNF-β mediated these associations. This MR study provides robust evidence supporting causal relationships between specific skin microbiota taxa and allergic diseases, as well as potential mediating roles of inflammation biomarkers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.